ImmuPharma plc (LON:IMM – Get Free Report)’s share price dropped 9.4% during trading on Thursday . The stock traded as low as GBX 3.82 ($0.05) and last traded at GBX 3.90 ($0.05). Approximately 12,650,292 shares were traded during trading, a decline of 36% from the average daily volume of 19,725,383 shares. The stock had previously closed at GBX 4.31 ($0.05).
ImmuPharma Stock Performance
The firm’s fifty day simple moving average is GBX 2.67 and its 200 day simple moving average is GBX 2.01. The stock has a market capitalization of £15.92 million, a price-to-earnings ratio of -382.20 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- Following Congress Stock Trades
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to Capture the Benefits of Dividend Increases
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- Election Stocks: How Elections Affect the Stock Market
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
